19 results
424B3
PTPI
Petros Pharmaceuticals Inc
14 Jan 22
Prospectus supplement
5:18pm
or clinical trials, which could result in regulatory sanctions and cause serious harm to Petros’ reputation.
Additionally, Petros is subject to the risk … proprietary and confidential information, which could harm our business and reputation or cause us to incur increased expenses to address any
424B5
byzhnu0
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
pj80cl00
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B5
s0j1nkxvgyt5g
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-K
wntw07l41bbe1ufc71jh
31 Mar 21
Annual report
4:30pm
S-3
wq90 cnsr
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-10.1
1r17decyb2rh8
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
424B3
duyjxcgc17fl
2 Nov 20
Prospectus supplement
12:00am
S-4/A
vvn jshwei
30 Sep 20
Registration of securities issued in business combination transactions (amended)
9:21am
S-4
40obwg vvp4udfnq2e
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next